1. Home
  2. AAME vs LITS Comparison

AAME vs LITS Comparison

Compare AAME & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$3.06

Market Cap

50.6M

Sector

Finance

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.51

Market Cap

55.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAME
LITS
Founded
1968
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
55.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AAME
LITS
Price
$3.06
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.1K
795.4K
Earning Date
11-14-2025
02-11-2026
Dividend Yield
0.69%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
$208,218,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.91
N/A
Revenue Growth
11.99
N/A
52 Week Low
$1.25
$1.30
52 Week High
$3.71
$9.00

Technical Indicators

Market Signals
Indicator
AAME
LITS
Relative Strength Index (RSI) 60.47 N/A
Support Level $2.59 N/A
Resistance Level $3.15 N/A
Average True Range (ATR) 0.28 0.00
MACD 0.05 0.00
Stochastic Oscillator 75.56 0.00

Price Performance

Historical Comparison
AAME
LITS

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: